Bod chief executive Jo Patterson said the company had access to the world’s only consistent, reproducible, manufactured cannabis extract through Linnea.
The Sydney-based company expects to receive approval to import the extract in the coming months and it would then initially target sales at 25 approved prescribers of medicinal cannabis.
Ms Patterson said while the main focus was increasing its distribution around Australia, China was emerging as an expansion option. “We really are focused on getting our home ground right and exploding into those distribution channels, which will be the springboard into China.”
So cheap imo. Things should really start to fly next month.
Anybody among the consortium meeting with Linnea management currently?
BDA Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held